Navigation Links
Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions
Date:6/13/2009

Customer-focused solutions in molecular imaging offer greater long-term value

TORONTO, June 13 /PRNewswire/ -- At the 2009 SNM Annual Meeting in Toronto this week, Siemens (booth #1024) is breaking down barriers to market entry, as well as offering versatile, multipurpose solutions that help physicians provide high quality patient care, and effectively manage healthcare costs. As the healthcare landscape changes within the United States and internationally, Siemens molecular imaging solutions offer options at all purchasing levels. The Biograph(TM) mCT, the world's first molecular CT, will be shown at SNM for the first time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

"Enabling our partners to maintain clinical viability and provide value to the patients they serve is critical to our mission during these challenging economic times. It is, therefore, imperative that we find a way to offer our customers both high-quality solutions and access to advanced technologies," said Michael Reitermann, chief executive officer, Molecular Imaging, Siemens Healthcare. "Though we've recently made some progress in U.S. imaging reimbursement policies, we need to further develop evidence-based data on a global level, so that we can continue to prove the clinical and financial efficacy of molecular imaging technology as a valuable asset to detect, stage and monitor disease."

As part of Siemens Molecular Imaging's commitment to innovation and access, it has recently released several new systems into the PET-CT and SPECT-CT markets that allow facilities with limited budgets, or those under financial constraints, to provide molecular imaging technology to their patients:

  • The Biograph mCT, the world's first molecular CT, will be shown at SNM for the first time. It enables facilities to serve both the nuclear medicine and the radiology department with one system. It achieves this duality through the integration of powerful PET and CT technologies, offering High-Definition PET, time-of-flight technology, and CT configurations up to 128 slices. Biograph mCT is ultra-efficient, offering institutions cutting-edge technology, optimum patient care solutions and potential for increased return on investment.
  • Siemens Biograph(TM) TruePoint 16-slice PET-CT is the latest addition to the Biograph family of clinical scanners. This affordable and reliable imaging system has high performance capabilities, including HD-PET and routine, 10-minute whole-body imaging. Biograph 16 is also mobile-ready, equipped to maximize on-location patient throughput and serve multiple communities.
  • Siemens Symbia(R) family of SPECT and SPECT-CT scanners is flexible enough to meet the changing needs of any imaging facility. Symbia E, and Symbia S and T are economical yet powerful points of entry into SPECT and SPECT-CT imaging for facilities that currently do not offer molecular imaging or for facilities with a limited budget. Now available with a broad range of specialty diagnostic tools, Symbia systems can be used for oncology, cardiology, neurology, and general imaging purposes, satisfying the needs of most facilities. Symbia S systems limit obsolescence by offering institutions a future-ready system that is field-upgradeable to diagnostic SPECT-CT.
  • New solutions in system applications that will be shown at SNM 2009 in Toronto include a new thin-client solution for SPECT systems, Symbia(R).net. This new application allows for increased workflow efficiency, ease of use and portability for users.
  • PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc., operates the largest PET radiopharmacy network with more than 52 molecular imaging radiopharmacies and distribution centers at multiple worldwide locations. With a network of radiopharmacies, PETNET guarantees reliable dose delivery to meet the needs of hospitals, clinics, and research facilities. Siemens PETNET operations have strategically expanded to include international locations and to provide SPECT radiopharmaceuticals through an agreement with Covidien Medical Imaging, further developing its PET and SPECT coverage.

As the global economic crisis continues, and the healthcare environment continues to evolve, Siemens is committed to offering the most advantageous and innovative systems at the most cost-efficient price points.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs around 49,000 people worldwide and operates in 130 countries. In the fiscal year 2008 (Sept. 30), Siemens Healthcare reported sales of euro 11.2 billion, orders of euro 11.8 billion, and Sector profit of euro 1.2 billion. Further information can be found by visiting http://www.siemens.com/healthcare.


'/>"/>
SOURCE Siemens Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Siemens Extends Tender Offer for Acquisition of Dade Behring
2. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
3. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
4. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
5. VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
6. Siemens Building Technologies Pioneers Wireless Solution for St. Anthonys Sensitive Environment
7. Susquehanna Health and Siemens Announce Plans to Improve Hospital Facilities Through Technology Investment
8. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
9. VIDEO from Medialink and Siemens: Worlds Smallest Ultrasound Package Launches in the U.S.
10. Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007
11. James Cracknell Launches Siemens Stroke for Stroke Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... ... April 22, 2017 , ... ... as Vice President of Sales and Business Development at OAKWORKS, Inc. Mr. ... engagements, business development, and strategic planning for the company. Recognized industry-wide as ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... An April ... of a pair of ancient teeth, which reveal a great deal about prehistoric ice-age ... a sharp stone may have been used to remove decayed dental matter, and that ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to ... in the 2017 London Marathon. Set to take place on April 23rd, the London Marathon ... Dr. Schwartz will run as part of team EMPOWER, raising money for the international charity, ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Chicago plastic surgeon, ... removal of osteoma. An osteoma is a benign bony lump located on the forehead ... and can cause difficulties with sight and pain. Dr. Shah has discovered an approach ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: